Skip to main content
logo
CSL Limited (ASX:CSL)
Australia flag Australia · Delayed Price · Currency is AUD
178.24
-5.98 (-3.25%)
Oct 1, 2026, 4:10 PM AEST

CSL Limited Revenue

In the fiscal year ending June 30, 2026, CSL Limited had annual revenue of $15.80B USD with 1.54% growth. CSL Limited had revenue of $7.47B in the half year ending June 30, 2026, with 10.64% growth.

Revenue
$15.80B
Revenue Growth
+1.54%
P/S Ratio
3.86
Revenue / Employee
$544.72K
Employees
29,000
Market Cap
88.23B AUD

Revenue Chart

Chart
* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202615.80B239.00M1.54%
Jun 30, 202515.56B758.00M5.12%
Jun 30, 202414.80B1.49B11.19%
Jun 30, 202313.31B2.75B26.02%
Jun 30, 202210.56B252.00M2.44%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Telix Pharmaceuticals1.29B
Mesoblast173.82M
Clinuvel Pharmaceuticals94.02M
BLS Pharmaceuticals73.91M
Neuren Pharmaceuticals69.53M
PYC Therapeutics25.99M
Actinogen Medical12.67M
Starpharma Holdings12.67M
Revenue Rankings

CSL Limited News

More News